Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Everolimus plus steroids versus low-dose calcineurin inhibitor, low-dose MMF, and steroids after kidney transplantation
NL-OMON35450Phase 4Active, not recruiting
- Sponsor
- University Medical Center Groningen
- Start
- Mar 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of everolimus, mycophenolate mofetil and corticosteroids in Kidney allograft status (RTx) (2 arms), sponsored by University Medical Center Groningen. Primary endpoints: Renal function and Need for reconversion to original therapy. Started Mar 2010; status: active, not recruiting.
02
Drugs
everolimusmycophenolate mofetilcorticosteroids
03
Conditions
Kidney allograft status (RTx)
Beyond the preview
Go deeper on NL-OMON35450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON35450.